Policies and Regulations-Jiangxi Institute | Jiangxi Biology

股票代码：******

OA Login

Language

Feb 22,2017

Provincial Party Committee and Provincial Government's "Several Opinions on Reducing Enterprise Costs and Optimizing the Development Environment" (80 Articles)

To deeply advance supply-side structural reform, effectively reduce enterprise costs, optimize the business development environment, enhance enterprise profitability, promote the province's sustained and healthy economic development, and ensure a good start to the 13th Five-Year Plan, the Provincial Party Committee and Provincial Government have decided to launch a special campaign across the province to reduce enterprise costs and optimize the development environment (hereinafter referred to as the special campaign). 1. Overall Requirements: Fully implement the spirit of the 18th National Congress of the Communist Party of China and the Third, Fourth, and Fifth Plenary Sessions of the 18th Central Committee, follow the deployment of the Central Economic Work Conference and relevant reform requirements of the Provincial Party Committee and Provincial Government, and carry out various forms of special activities under the theme of "reducing enterprise costs and optimizing the development environment."

See more+

Dec 13,2015

Regulations on Reporting and Monitoring of Adverse Drug Reactions

"Measures for the Reporting and Monitoring of Adverse Drug Reactions" (Ministry of Health Order No. 81) issued on May 4, 2011, Ministry of Health of the People's Republic of China Order No. 81. The "Measures for the Reporting and Monitoring of Adverse Drug Reactions" were reviewed and approved at the Ministry of Health executive meeting on December 13, 2010, and are hereby promulgated, effective from July 1, 2011. Minister Chen Zhu May 4, 2011 Adverse Drug Reaction Reporting and Monitoring

See more+

Dec 13,2015

Drug Recall Management Measures

Order No. 29 of the State Food and Drug Administration: The "Drug Recall Management Measures" was reviewed and approved by the State Food and Drug Administration's bureau meeting on December 6, 2007, and is hereby promulgated and shall come into effect from the date of promulgation. Director Shao Mingli December 10, 2007 Drug Recall Management Measures Chapter 1 General Provisions Article 1 To strengthen drug safety supervision and ensure public medication safety, in accordance with the "Drug Administration Law of the People's Republic of China," the "Implementation Regulations of the Drug Administration Law of the People's Republic of China," and the "State Council's Special Regulations on Strengthening the Supervision and Administration of Food and Other Product Safety"

See more+

Dec 13,2015

Good Manufacturing Practice for Pharmaceutical Products 2010 Revision

Good Manufacturing Practice for Pharmaceutical Products (2010 Revision) (Ministry of Health Order No. 79) Issued on February 12, 2011 Ministry of Health of the People's Republic of China Order No. 79 The "Good Manufacturing Practice for Pharmaceutical Products (2010 Revision)" was reviewed and approved by the Ministry of Health Executive Meeting on October 19, 2010, and is hereby promulgated, effective from March 1, 2011. Minister Chen Zhu January 17, 2011 Chapter 1 General Provisions Article 1 To standardize the quality management of pharmaceutical production, in accordance with the "Drug Administration Law of the People's Republic of China" and the "China

See more+

Dec 13,2015

Good Supply Practice for Pharmaceutical Products

Good Manufacturing Practice for Pharmaceutical Operation (Ministry of Health Order No. 90) National Health and Family Planning Commission of the People's Republic of China www.moh.gov.cn Order No. 90 The "Good Manufacturing Practice for Pharmaceutical Operation" was reviewed and approved by the Ministry of Health's executive meeting on November 6, 2012, and is hereby promulgated, effective from June 1, 2013. Minister Chen Zhu January 22, 2013 Good Manufacturing Practice for Pharmaceutical Operation Chapter 1 General Provisions Article 1 To strengthen the quality management of pharmaceutical operation, regulate pharmaceutical operation behavior, and ensure the safety and effectiveness of human medication, according to

See more+

Dec 13,2015

Drug Administration Law of the People's Republic of China

(Adopted at the 7th meeting of the Standing Committee of the 6th National People's Congress on September 20, 1984, amended at the 20th meeting of the Standing Committee of the 9th National People's Congress on February 28, 2001, revised according to the Decision on Amending Seven Laws Including the at the 6th meeting of the Standing Committee of the 12th National People's Congress on December 28, 2013, and the Decision on Amending the at the 14th meeting of the Standing Committee of the 12th National People's Congress on April 24, 2015) First

See more+

< 1 2 >

Add:

Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China

Board Office:

Domestic Sales:

International Sales: